focus -WSS

focus

author：entertainment 2025-09-27 17:02:34 - browse：484

Neumora, a privately held biotech company, is moving into the final phase of testing with a novel treatment for depression that showed promise in a mid-stage trial.

The drug, a daily pill called navacaprant, led to statistically significant improvements over placebo on a measurement of disease severity for patients with moderate to severe major depressive disorder, Neumora said Tuesday. In the eight-week study, the medicine also led to improvements in patient-reported anhedonia, a reduced ability to experience pleasure that often accompanies severe depression.

Navacaprant’s statistically significant benefits came from a pre-specified subset of 100 patients in a study that enrolled 171 people. In the total population, including 71 patients who had mild to moderate disease, navacaprant’s effect on depressive symptoms was numerically superior to placebo but did not reach the threshold of statistical significance, missing the study’s primary endpoint.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Watch the official trailer for 'Ahsoka' series

WSS

Inflation cooled significantly in June, bringing price hikes close to normal levels

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Antibody drugs appear effective. Now can we make enough of them?

Elizabeth Holmes on track for early release from her 11

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

A Greenpeace activist is fined for crash

knowledge

focus

explore

Tori Bowie and the unacceptable rates of Black maternal death

Iowa House, Senate pass 6

New air purifier tech could be key to improving indoor air quality

Palantir health business leans on meeting customers’ needs

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

N.Y. state detects polio case, first in the U.S. since 2013

Trump demands the U.S. pay no more for drugs than other countries … again

NIH fellows want a pay raise. Will that mean less money for grants?

Walensky prepares to leave CDC — and Congress — behind

New research casts further doubt on a common procedure used with IVF

hotspot

Digital health funding stays low as a new reality sets in

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Britney Spears to release memoir, 'The Woman In Me,' later this year

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

How are insurers handling Leqembi and related scans?

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

leisure time

hotspot

focus

knowledge